Programs & Events
Podcast shares AbSPORU data success and patient-engagement best-practices
The Alberta SPOR SUPPORT Unit Methods Support and Development Platform is a leader in sharing innovative research methods through its support of the Method’s Hub Podcast Series. Recently Podcast 10 featured Dr. Finlay McAlister, the Lead of the AbSPORU Data Platform who shared how his platform helps support clinical and health researchers get access to health data. Dr. McAlister provides an overview of the services offered by the Data Platform and how his staff work with researchers to help them get access to health data. Did you know that the AbSPORU Data Platform has reduced the wait time for health data in Alberta from months to approximately two days on average? Another podcast, Number 11, focused on implementing patient reported outcomes in paediatric practice using the KLIK website. This podcast featured Dr. Lotte Haverman, a post-doc researcher and paediatric psychologist at the Emma Children’s Hospital of the Academic Medical Center in Amsterdam, the Netherlands. Dr. Haverman discusses the importance of using a web-based method to give a clear overview of how chronically ill patients (children and their parents/caregivers) are doing. Through the KLIK website, patients and families can fill out questionnaires about their daily life, which allows paediatricians to know how their patients are functioning with regards to psychosocial aspects and Health Related Quality of Life. If you would like to learn more about the Methods Hub webcast or have an idea for a future webcast click HERE.
Training and Events:
Patient-Oriented Basics: Patient-Oriented Research for Patient Partners: Learn the basics of patient-oriented research including, what is health research? What is the research cycle? and Learn about patient engagement. The 40 minute session is hosted by the Patient Engagement Platform, on Adobe Connect. Click here to stream Patient-Oriented Basics.
Ethics and Patient Engagement: Understanding the Ethical Considerations and Requirements of Engaging Patients in Health Research: Learn when patients are partners in research, they are not seen as “participants” and require no unique approval. However, there are still ethical considerations. This 10 minute session is hosted by the Patient Engagement Platform. Click here to stream Ethics and Patient Engagement.
September 20th to the 21st: Introduction to Health Research: Partake in a free two day course designed to give patients and public members a basic introduction and understanding of health research. The course will take place in Calgary from 9:00 am to 4:00 pm on September 20th and 21st. The Patient Engagement Platform will host the session. Click HERE to register for the course.
October 18th to the 21st: Introduction to Health Research: Partake in a free two day course designed to give patients and public members a basic introduction and understanding of health research. The course will take place in Edmonton from 9:00 am to 4:00 pm. The Patient Engagement Platform will be hosting the event. Click HERE to register for the course.
Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team
Stand Up to Cancer (SU2C) Canada, in partnership with the Canadian Cancer Society (CCS) and the Canadian Institutes of Health Research (CIHR) – Institute of Cancer Research (ICR) are pleased to announce a new funding opportunity: the Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team, supported by CCS and CIHR.
A webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email to email@example.com by July 9, 2018. Details for the July 16, 2018 webinar which will be from 1:00 pm to 2:00 pm EST, will be provided in advance to interested applicants.
- Letter of intent due August 10, 2018
- Full application due (invited) October 26, 2018
- Anticipated funding start date in early 2019
The SU2C Canada Metastatic Breast Cancer (MBC) Dream Team represents a new, focused effort to implement advances in metastatic cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research “Metastatic Breast Cancer Dream Team”. The most talented and promising researchers across Canadian institutions will be assembled into a pan-Canadian Dream Team, forming an optimal configuration of expertise needed to solve key problems in metastatic cancer and positively impact patients in the near future.
The successful MBC Dream Team will span multiple disciplines and utilize new tools of modern biology to attack research questions in a coordinated way. SU2C Canada. CCS and the CIHR believe that this unique Dream Team model will advance scientific research in the interests of both today’s cancer patients and those who may develop cancer in the future.
Total funds of up to $6 million CAD are available from the funders over a 4-year research term. The funds must be used for research at Canadian institutions.
Research as part of CCS: Note that as of last year, the Canadian Cancer Society has begun referring to the Canadian Cancer Society Research institute (CCSRI) as simply the Canadian Cancer Society (CCS). This is reflected in their new, exciting and cohesive vision for the organization and their commitment to research as a key priority for CCS The excellent research that was previously funded through the NCIC and CCSRI continues to be an integral part of their overall mission and is not seperate or removed from the rest of the organization. With this in mind, they ask going forward all credit for research funding be attributed simply to the “Canadian Cancer Society”.
Canadian Cancer Society: Travel Awards
Applicants for the September 15, 2018 Travel Awards competition can now apply online. A limited number of Travel Awards to PhD or MD/PhD students, and post-doctoral/medical/clinical fellows are available. The purpose of this program is to defray the travel costs associated with making a scientific presentation as a first author or presenter at a conference, symposium or other appropriate professional meeting.
Please Note: Starting with the January 2019 competition, applications will be accepted for conference dates within 6 months following the funding start date.
Click HERE for more information regarding this award, and to apply.
Canadian Cancer Society: Junior Investigator Grant Panel Travel Award
The Canadian Cancer Society is pleased to offer a special initiative to allow junior investigators in cancer research to gain knowledge and understanding of the Canadian Cancer Society peer-review process.
Selected investigators from across Canada will be provided funds to reimburse travel costs to Toronto to observe a grant panel meeting. This unique opportunity will provide junior faculty members with an “inside look” at how research grants are reviewed in order to help structure their own grant proposals in the future.
Applications for these limited funds will be accepted via EGrAMS and required Department or Institution Head sign-off prior to submission.
Click HERE for more information regarding this award, and to apply.